Clear Search

Books+ Search Results

Recently Added: Is
Is Is Not
within 1 Month
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical biotechnology
Subject: Is
Is Is Not
Drug development

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Results are already all online
Viewing Online Items
1.
Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010.
Online
Online book
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
2.
Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
4.L 11/4:S.HRG.110-375
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online